PIMA534885
CTHRC1 Monoclonal Antibody (5H1), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA534885-Each-of-1 | In Stock | ₹ 46,947.50 |
PIMA534885 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,947.50
GST (18%): ₹ 8,450.55
Total Price: ₹ 55,398.05
Antigen
CTHRC1
Classification
Monoclonal
Concentration
2.0 mg/mL
Formulation
PBS with 0.2% BSA, 50% glycerol and 0.05% sodium azide; pH 7.4
Gene Accession No.
Q96CG8
Gene Symbols
Cthrc1
Immunogen
Recombinant protein within Human CTHRC1 aa 1-243
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG1
Applications
Immunohistochemistry (Paraffin), Western Blot
Clone
5H1
Conjugate
Unconjugated
Gene
Cthrc1
Gene Alias
1110014B07Rik; collagen triple helix repeat containing 1; collagen triple helix repeat-containing protein 1; CTHRC1; Protein NMTC1; UNQ762/PRO1550
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Gene ID (Entrez)
115908
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles, store in dark
Form
Liquid
Related Products
Description
- Positive Control: CTHRC1 recombinant protein, rat large intestine tissue, human kidney tissue, human placenta tissue
- The Collagen triple helix repeat-containing protein (CTHRC1) is a glycosylated, secreted protein that is transiently expressed in the arterial wall in response to injury where it is thought to contribute to vascular remodeling by inhibiting collagen expression and deposition and promoting cell migration
- CTHRC1 is highly expressed multiple human cancers, including pancreatic cancer where it plays a significant role in the progression and metastasis of the disease by regulating migration and adhesion of tumors cells
- CTHRC1 overexpression can also be used as an independent prognostic marker in gastric cancer
- Mutations at this locus have been associated with Barrett esophagus and esophageal adenocarcinoma.